Measles-containing-vaccine first-dose (MCV1) immunization coverage in Sierra Leone
Sierra Leone: Measles-containing-vaccine first-dose (MCV1) immunization coverage was 90.0% in 2025. ▲ Rising
Measles-containing-vaccine first-dose (MCV1) immunization coverage in Sierra Leone, 2000–2025
Source: World Health Organization, Global Health Observatory.
Analysis
Sierra Leone recorded 90.0% for measles-containing-vaccine first-dose (mcv1) immunization coverage in 2025.
Compared with earlier readings it is up 15.4% over ten years.
Over the whole period, measles-containing-vaccine first-dose (mcv1) immunization coverage in Sierra Leone peaked at 93.0% in 2019 and was at its lowest, 37.0%, in 2000.
That places Sierra Leone 97th out of 194 countries with data for 2025, putting it in the middle of the range.
The long-run direction has been consistently rising across the 26 years of available data.
Measles-containing-vaccine first-dose (MCV1) immunization coverage in Sierra Leone, year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 37.0% | — |
| 2001 | 50.0% | +35.1% |
| 2002 | 62.0% | +24.0% |
| 2003 | 73.0% | +17.7% |
| 2004 | 76.0% | +4.1% |
| 2005 | 71.0% | -6.6% |
| 2006 | 65.0% | -8.5% |
| 2007 | 60.0% | -7.7% |
| 2008 | 73.0% | +21.7% |
| 2009 | 80.0% | +9.6% |
| 2010 | 82.0% | +2.5% |
| 2011 | 84.0% | +2.4% |
| 2012 | 86.0% | +2.4% |
| 2013 | 85.0% | -1.2% |
| 2014 | 80.0% | -5.9% |
| 2015 | 78.0% | -2.5% |
| 2016 | 85.0% | +9.0% |
| 2017 | 80.0% | -5.9% |
| 2018 | 87.0% | +8.8% |
| 2019 | 93.0% | +6.9% |
| 2020 | 87.0% | -6.5% |
| 2021 | 87.0% | +0.0% |
| 2022 | 90.0% | +3.4% |
| 2023 | 90.0% | +0.0% |
| 2024 | 90.0% | +0.0% |
| 2025 | 90.0% | +0.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 64.7% | 37.0% | 80.0% | 10 |
| 2010s | 84.0% | 78.0% | 93.0% | 10 |
| 2020s | 89.0% | 87.0% | 90.0% | 6 |
Countries ranked near Sierra Leone
More health data for Sierra Leone
- Un projection of annual infant deaths, annual growth rate -2.34 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.773 % change on previous year (2090)
- Heat deaths vs projected death rates 1,199 (2090)
- Un projection of annual infant deaths 4,209 (2100)
- Population ages 0-14, female, annual growth rate 0.8723 % change on previous year (2025)
- Population ages 0-14, female, per unit of GDP 0.0002 units per US$ of GDP (2025)
- Population ages 0-14, female, per capita 0.1868 units per person (2025)
- Population ages 0-14, male, annual growth rate 0.8951 % change on previous year (2025)
- Population ages 0-14, male, per unit of GDP 0.0002 units per US$ of GDP (2025)
- Population ages 0-14, male, per capita 0.1897 units per person (2025)
Frequently asked questions
- What is measles-containing-vaccine first-dose (mcv1) immunization coverage in Sierra Leone?
- Measles-containing-vaccine first-dose (mcv1) immunization coverage in Sierra Leone was 90.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest measles-containing-vaccine first-dose (mcv1) immunization coverage recorded in Sierra Leone?
- The highest recorded value was 93.0% in 2019.
- What is the lowest measles-containing-vaccine first-dose (mcv1) immunization coverage recorded in Sierra Leone?
- The lowest recorded value was 37.0% in 2000.
- How does Sierra Leone rank for measles-containing-vaccine first-dose (mcv1) immunization coverage?
- Sierra Leone ranks 97th out of 194 countries with data for 2025.
- Is measles-containing-vaccine first-dose (mcv1) immunization coverage rising or falling in Sierra Leone?
- Over the last ten years it is up 15.4%. The long-run trend across the full record is rising.
- Where does this Sierra Leone data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Measles-containing-vaccine first-dose (MCV1) immunization coverage among 1-year-olds (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).